PL2103306T3 - Zastosowanie kwasu glutaminowego do zapobiegania/polepszania czynnościowego zaburzenia trawienia - Google Patents

Zastosowanie kwasu glutaminowego do zapobiegania/polepszania czynnościowego zaburzenia trawienia

Info

Publication number
PL2103306T3
PL2103306T3 PL09005515T PL09005515T PL2103306T3 PL 2103306 T3 PL2103306 T3 PL 2103306T3 PL 09005515 T PL09005515 T PL 09005515T PL 09005515 T PL09005515 T PL 09005515T PL 2103306 T3 PL2103306 T3 PL 2103306T3
Authority
PL
Poland
Prior art keywords
preventing
glutamic acid
digestive disorder
improving functional
functional digestive
Prior art date
Application number
PL09005515T
Other languages
English (en)
Inventor
Hisayuki Uneyama
Tatsuro Tanaka
Kunio Torii
Shinichi Fujita
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Publication of PL2103306T3 publication Critical patent/PL2103306T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20—Synthetic spices, flavouring agents or condiments
    • A23L27/23—Synthetic spices, flavouring agents or condiments containing nucleotides
    • A23L27/235—Synthetic spices, flavouring agents or condiments containing nucleotides containing also amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Packages (AREA)
  • Saccharide Compounds (AREA)
  • Seasonings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL09005515T 2004-09-17 2005-09-16 Zastosowanie kwasu glutaminowego do zapobiegania/polepszania czynnościowego zaburzenia trawienia PL2103306T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004271884 2004-09-17
EP05785845A EP1806134B1 (en) 2004-09-17 2005-09-16 Agent and food for preventing/improving functional digestive disorder
EP09005515A EP2103306B1 (en) 2004-09-17 2005-09-16 Use of glutamic acid for preventing/improving functional digestive disorder

Publications (1)

Publication Number Publication Date
PL2103306T3 true PL2103306T3 (pl) 2012-12-31

Family

ID=36060214

Family Applications (2)

Application Number Title Priority Date Filing Date
PL09005515T PL2103306T3 (pl) 2004-09-17 2005-09-16 Zastosowanie kwasu glutaminowego do zapobiegania/polepszania czynnościowego zaburzenia trawienia
PL05785845T PL1806134T3 (pl) 2004-09-17 2005-09-16 Środek i produkt żywnościowy do zapobiegania/leczenia czynnościowych zaburzeń trawiennych

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL05785845T PL1806134T3 (pl) 2004-09-17 2005-09-16 Środek i produkt żywnościowy do zapobiegania/leczenia czynnościowych zaburzeń trawiennych

Country Status (13)

Country Link
US (2) US20070218112A1 (pl)
EP (3) EP2305241A1 (pl)
JP (1) JP4124260B2 (pl)
KR (2) KR101153242B1 (pl)
CN (3) CN102379891A (pl)
AU (1) AU2005283297B2 (pl)
BR (1) BRPI0515413B8 (pl)
CA (1) CA2580692C (pl)
ES (2) ES2388609T3 (pl)
MX (1) MX2007003196A (pl)
PL (2) PL2103306T3 (pl)
RU (3) RU2407524C2 (pl)
WO (1) WO2006030980A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008010472A1 (en) * 2006-07-18 2008-01-24 Ajinomoto Co., Inc. Total enteral nutrition composition
JP5408882B2 (ja) * 2008-01-23 2014-02-05 ヤマサ醤油株式会社 唾液分泌促進剤
WO2009100265A2 (en) 2008-02-08 2009-08-13 Colgate-Palmolive Company Compositions and methods for the treatment of xerostomia
JPWO2009113594A1 (ja) * 2008-03-11 2011-07-21 味の素株式会社 機能性消化管障害予防・改善剤および食品
WO2010104175A1 (ja) 2009-03-13 2010-09-16 味の素株式会社 経口用組成物
WO2013129642A1 (ja) * 2012-03-02 2013-09-06 協和発酵バイオ株式会社 摂食活動および／または消化管活動促進剤
JP6067292B2 (ja) * 2012-03-19 2017-01-25 サッポロビール株式会社 セロトニン分泌促進剤
WO2013161815A1 (ja) * 2012-04-23 2013-10-31 味の素株式会社 グルタミン酸及びアルギニン高含有錠剤
JP2013224322A (ja) * 2013-07-03 2013-10-31 Yamasa Shoyu Co Ltd 唾液分泌促進剤
WO2015084158A1 (en) 2013-12-06 2015-06-11 N.V. Nutricia A pyrimidine derivative and a fatty acid source for use in the treatment of constipation
KR102233266B1 (ko) * 2014-07-09 2021-03-30 농업회사법인 주식회사 생명의나무 시티딜산, 아데닐산 또는 이들의 염을 유효성분으로 하는 헬리코박터 파이로리 감염 예방 또는 치료용 조성물
WO2016053085A1 (en) 2014-09-30 2016-04-07 N.V. Nutricia Composition comprising a uridine source and butyrate producing fibres for preventing gastrointestinal disorders
CN105902572A (zh) * 2016-02-26 2016-08-31 四川好医生攀西药业有限责任公司 一种治疗胃食管反流病的药物组合物及其制备方法和应用
CN106420790A (zh) * 2016-09-13 2017-02-22 北京大学 次黄嘌呤核苷酸在制备心肌力增强制剂中的用途
US11208568B2 (en) * 2017-05-17 2021-12-28 Elwha Llc Thermal signature control structures

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE786721A (fr) 1971-08-19 1973-11-16 Pechiney Ugine Kuhlmann Perfectionnement a la palettisation de charges elementaires nonrigides
JPS5920229B2 (ja) 1979-10-17 1984-05-11 沖電気工業株式会社 ジヤンクタ障害検出方式
JPS5888323A (ja) * 1981-11-20 1983-05-26 Riyoushiyoku Kenkyukai 乳幼児用成分栄養組成物
KR890001236B1 (ko) * 1985-10-02 1989-04-28 화이자 인코포레이티드 소염제 조성물의 제조방법
SE8704217D0 (sv) 1987-10-29 1987-10-29 Vinnars Erik Ab Aminosyrakomposition for parenteral neringstillforsel
DE4133366A1 (de) 1991-10-09 1993-04-15 Nycomed Arzneimittel Gmbh Zusammensetzung zur verhinderung von schaeden in geweben durch sauerstoffunterversorgung
JPH07114646B2 (ja) * 1993-01-04 1995-12-13 味の素株式会社 調味食品
US20040062802A1 (en) * 1998-04-02 2004-04-01 Hermelin Victor M. Maximizing effectiveness of substances used to improve health and well being
US6624150B2 (en) * 1999-02-26 2003-09-23 Inspire Pharmaceuticals, Inc. Method of treating gastrointestinal tract disease with purinergic receptor agonists
PT1062879E (pt) * 1999-06-26 2003-12-31 Braun Melsungen Ag Solucao aquosa para nutricao parenteral
JP4010390B2 (ja) * 1999-09-20 2007-11-21 明治乳業株式会社 免疫賦活化組成物
JP2003524636A (ja) * 1999-12-22 2003-08-19 インスパイアー ファーマシューティカルズ，インコーポレイティド プリン性受容体アゴニストによる胃腸管の処置方法
NL1014380C2 (nl) 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
GB0009056D0 (en) * 2000-04-12 2000-05-31 Nestle Sa Composition comprising free amino acids
BR0206980A (pt) * 2001-02-05 2004-07-06 Michael Albert Kamm Uso de um modulador do tÈnus do músculo liso
US20040005304A1 (en) * 2002-07-08 2004-01-08 Mak Wood, Inc. Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
WO2004047737A2 (en) * 2002-11-21 2004-06-10 Dss Global, Inc. Nucleotide based medicament and method of use for treatment of conditions in humans
JP2004271884A (ja) 2003-03-07 2004-09-30 Matsushita Electric Ind Co Ltd 光メモリ記録媒体および光メモリ装置
WO2006001492A1 (ja) * 2004-06-28 2006-01-05 Ajinomoto Co., Inc. 栄養組成物および消化管機能低下予防・改善用組成物

Also Published As

Publication number Publication date
AU2005283297A1 (en) 2006-03-23
EP2305241A1 (en) 2011-04-06
RU2010136914A (ru) 2012-03-10
CN101052390A (zh) 2007-10-10
US20090291910A1 (en) 2009-11-26
ES2388609T3 (es) 2012-10-16
BRPI0515413B8 (pt) 2021-05-25
BRPI0515413A (pt) 2008-07-22
EP2103306A3 (en) 2009-12-23
KR101153242B1 (ko) 2012-06-08
EP2103306B1 (en) 2012-06-06
KR20070053352A (ko) 2007-05-23
WO2006030980A1 (ja) 2006-03-23
US20070218112A1 (en) 2007-09-20
BRPI0515413B1 (pt) 2021-04-27
CA2580692C (en) 2014-03-18
PL1806134T3 (pl) 2012-12-31
EP2103306A2 (en) 2009-09-23
KR101086628B1 (ko) 2011-11-25
KR20090086450A (ko) 2009-08-12
CN101052390B (zh) 2011-12-14
ES2384294T3 (es) 2012-07-03
EP1806134B1 (en) 2012-07-11
CN102379891A (zh) 2012-03-21
EP1806134A4 (en) 2007-12-26
RU2407524C2 (ru) 2010-12-27
MX2007003196A (es) 2007-05-16
JP4124260B2 (ja) 2008-07-23
CA2580692A1 (en) 2006-03-23
CN102379865A (zh) 2012-03-21
JPWO2006030980A1 (ja) 2008-05-15
RU2007114297A (ru) 2008-10-27
RU2009110912A (ru) 2010-09-27
EP1806134A1 (en) 2007-07-11
AU2005283297B2 (en) 2011-12-08

Similar Documents

Publication Publication Date Title
HUE059645T2 (hu) Glutaminsav heterodimerei
IL223477A (en) Pharmaceutical preparation containing modified enzyme uricase
TWI365045B (en) Use of infant formula with reduced protein content
ZA200704789B (en) Novel anthranilic acid derivative or salt thereof
ZA200709745B (en) Compositions and methods for inhibiting gastric acid secretion
PL1685834T3 (pl) Zastosowanie kwasu pinolenowego do leczenia otyłości
IL179364A0 (en) 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
IL185790A0 (en) Amino acid derivatives
AP2007004001A0 (en) Novel dicarboxylic acid derivatives
IL179811A0 (en) Identification of tumors
EP1765761A4 (en) NOVEL ANALOGUES OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID
IL187655A0 (en) Anthranilic acid derivatives
GB0428384D0 (en) Eicosapentaenoic acid
EP1714976A4 (en) AMINO ACID SEQUENCES OF THE ACTIVE PRINCIPLE OF MOSCHUS AND ITS ACETIC ACID SALT AND THE PRODUCTION AND USE THEREOF
IL177647A0 (en) Use of enzyme
GB0408521D0 (en) Treatment of sepsis
ZA200805701B (en) Salts of styphnic acid
IL181417A0 (en) Chiral 3-halophthalic acid derivatives
GB0618060D0 (en) Treatment of polyamides
IL179151A0 (en) Synthesis of amino acid keto-epoxides
GB0420607D0 (en) Amino acid
GB0514194D0 (en) Measurement of gastric acid secretion
GB2421363A8 (en) Fastening for connector
GB0425900D0 (en) Novel pyrrolopyridine-2-carboxylic acid amide
PL365717A1 (pl) Amonal 40%